Pfizer’s RSV vaccine given breakthrough therapy status by FDA

March 9, 2022

Bristol Myers’ Opdivo and Cisplatin Combination Achieves Breakthrough in Initial Colorectal Cancer Treatment

December 13, 2023

Negative Confirmatory Study Results for Sarepta’s DMD Exon-Skippers

November 7, 2025

Must Read

Pfizer Reports 40% Reduction in Disease Progression Risk With Atirmociclib Combination in Mid-Stage Breast Cancer Study

March 19, 2026

BioMarin suspends dosing and enrollment in two Voxzogo studies

March 19, 2026

Structure Reports 16.3% Weight Loss for Oral Obesity Drug Aleniglipron in Phase 2 Study

March 19, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

$20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

Pfizer Reports 40% Reduction in Disease Progression Risk With Atirmociclib Combination in Mid-Stage Breast Cancer Study

BioMarin suspends dosing and enrollment in two Voxzogo studies

Structure Reports 16.3% Weight Loss for Oral Obesity Drug Aleniglipron in Phase 2 Study

Eli Lilly Reports Phase 3 Trial Results for Ebglyss in Children With Atopic Dermatitisv

R1 Therapeutics Announces Itself With $77.5M Series A Round to Tackle Kidney Disease

Medtronic to Acquire Scientia Vascular for $550 Million to Expand Stroke Care Device Portfolio

Boehringer Terminates MASH Deal With OSE as Part of Pipeline Narrowing

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

What Types of AI Are Used in Drug Discovery?

How Accurate Is AI in Predicting Drug Success?

FDA Regulatory Challenges for Biotech Companies: What Leaders Need to Know

Top 10 Most Credible Pharma and Biotech News Websites in 2026

Tag: reproxalap

FDA Issues Third Rejection for Aldeyra’s Reproxalap in Dry Eye Disease

Editor Picks

Pfizer’s RSV vaccine given breakthrough therapy status by FDA

Bristol Myers’ Opdivo and Cisplatin Combination Achieves Breakthrough in Initial Colorectal Cancer Treatment

Negative Confirmatory Study Results for Sarepta’s DMD Exon-Skippers

Must Read

Pfizer Reports 40% Reduction in Disease Progression Risk With Atirmociclib Combination in Mid-Stage Breast Cancer Study

BioMarin suspends dosing and enrollment in two Voxzogo studies

Structure Reports 16.3% Weight Loss for Oral Obesity Drug Aleniglipron in Phase 2 Study

Hot Topics

About Us

Follow Us